Evaluation of Cardiac Sympathetic Nerve Activity and Aldosterone Suppression in Patients With Decompensated Acute Heart Failure on the Treatment Containing Intravenous Atrial Natriuretic Peptide
Phase 4
- Conditions
- decompensated acute heart failure
- Registration Number
- JPRN-UMIN000009170
- Lead Sponsor
- Kitakanto Cardiovascular Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
1) Cardiogenic shock or hypotension 2) History of myocardial infarction or coronary artery disease 3) Severe heart failure requiring mechanical support (intraaortic balloon pumping, left ventricular assist device, or cardiac resynchronization therapy) 4) Requiring heart transplantation
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method I-123 MIBG scintigraphic parameters plasma aldosterone concentrations
- Secondary Outcome Measures
Name Time Method eft ventricular (LV) end-diastolic volume, end-systolic volume, and ejection fraction plasma BNP concentrations